Bevacizumab/docetaxel/gemcitabineMyelosuppression and epistaxis: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1429卷 / 1期

关键词：

Stem Cell; Sarcoma; Neutropenia; Bevacizumab; Thrombocytopenia;

D O I：

10.2165/00128415-201214290-00038

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：11 / 11

相关论文

共 50 条

[1] GemcitabineMyelosuppression and other toxicities: 3 case reports
[J]. Reactions Weekly, 2009, 1250 (1) : 21 - 21
[2] Bevacizumab/octreotideDiarrhoea, hypertension and epistaxis: 2 case reports
[J]. Reactions Weekly, 2020, 1792 (1) : 54 - 54
[3] Bevacizumab/fluorouracil/folinic acid/irinotecanNeutropenic sepsis, epistaxis and hypertension: 3 case reports
[J]. Reactions Weekly, 2015, 1552 (1) : 39 - 39
[4] Bevacizumab/carboplatin/vinorelbineDeep vein thrombosis and epistaxis: 2 case reports
[J]. Reactions Weekly, 2015, 1580 (1) : 65 - 65
[5] HeparinEcchymosis, epistaxis and menorrhagia: 3 case reports
[J]. Reactions Weekly, 2018, 1701 (1) : 137 - 137
[6] Docetaxel/gemcitabineDyspnoea: 3 case reports
[J]. Reactions Weekly, 1999, 775 (1) : 9 - 9
[7] Bevacizumab/ranibizumabEndophthalmitis: 3 case reports
[J]. Reactions Weekly, 2015, 1576 (1) : 61 - 61
[8] Bevacizumab/corticosteroidsOsteonecrosis: 3 case reports
[J]. Reactions Weekly, 2013, 1444 (1) : 11 - 11
[9] RomiplostimBronchitis, epistaxis and nasopharyngitis in children: 3 case reports
[J]. Reactions Weekly, 2012, 1419 (1) : 44 - 44
[10] Docetaxel/doxorubicinFebrile neutropenia: 3 case reports
[J]. Reactions Weekly, 2018, 1702 (1) : 101 - 101

← 1 2 3 4 5 →